Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2015 (2015), Article ID 381934, 8 pages
http://dx.doi.org/10.1155/2015/381934
Research Article

Pioglitazone Ameliorates Neuron Loss in the Cortex after Aluminum-Treatment in Rats

1Histomorphometry and Stereology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran
2Physiology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3Anatomy Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Received 8 March 2015; Revised 21 May 2015; Accepted 24 May 2015

Academic Editor: Jeff Bronstein

Copyright © 2015 Ali Rafati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Walton, “Chronic aluminum intake causes Alzheimer's disease: applying sir austin bradford hill's causality criteria,” Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 765–838, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Kumar and K. D. Gill, “Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review,” NeuroToxicology, vol. 41, pp. 154–166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Yase, S. Yoshida, T. Kihira, I. Wakayama, and J. Komoto, “Kii ALS dementia,” Neuropathology, vol. 21, no. 2, pp. 105–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Seamans, C. C. Lapish, and D. Durstewitz, “Comparing the prefrontal cortex of rats and primates: insights from electrophysiology,” Neurotoxicity Research, vol. 14, no. 2-3, pp. 249–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. X. Guo-Ross, E. Y. Yang, T. J. Walsh, and S. C. Bondy, “Decrease of glial fibrillary acidic protein in rat frontal cortex following aluminum treatment,” Journal of Neurochemistry, vol. 73, no. 4, pp. 1609–1614, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kim, “Perinatal exposure to aluminum alters neuronal nitric oxide synthase expression in the frontal cortex of rat offspring,” Brain Research Bulletin, vol. 61, no. 4, pp. 437–441, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Aviles-Olmos, P. Limousin, A. Lees, and T. Foltynie, “Parkinson's disease, insulin resistance and novel agents of neuroprotection,” Brain, vol. 136, no. 2, pp. 374–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zhu, J. Zhang, M. Ji et al., “The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPARγ in retinal neuroprotection,” PLoS ONE, vol. 8, no. 7, Article ID e68935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-B. Jia, X.-M. Wang, L.-L. Qiu et al., “Spinal neuroimmune activation inhibited by repeated administration of pioglitazone in rats after L5 spinal nerve transection,” Neuroscience Letters, vol. 543, pp. 130–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Bordet, T. Ouk, O. Petrault et al., “PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1341–1346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Gofflot, N. Chartoire, L. Vasseur et al., “Systematic gene expression mapping clusters nuclear receptors according to their function in the brain,” Cell, vol. 131, no. 2, pp. 405–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Hyde, N. K. Tyler, and C. G. Plopper, “Morphometry of the respiratory tract: avoiding the sampling, size, orientation, and reference traps,” Toxicologic Pathology, vol. 35, no. 1, pp. 41–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Nayak, S. B. Sharma, and N. V. S. Chowdary, “Aluminum and ethanol induce alterations in superoxide and peroxide handling capacity (SPHC) in frontal and temporal cortex,” Indian Journal of Biochemistry and Biophysics, vol. 50, no. 5, pp. 402–410, 2013. View at Google Scholar · View at Scopus
  14. V. Fekete, S. Vandevijvere, F. Bolle, and J. van Loco, “Estimation of dietary aluminum exposure of the Belgian adult population: evaluation of contribution of food and kitchenware,” Food and Chemical Toxicology, vol. 55, pp. 602–608, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Almasi-Nasrabadi, M. Javadi-Paydar, S. Mahdavian et al., “Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice,” Behavioural Brain Research, vol. 231, no. 1, pp. 138–145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wang, “Current researches on biological effect of aluminum,” Wei Sheng Yan Jiu, vol. 31, no. 4, pp. 320–322, 2002. View at Google Scholar · View at Scopus
  17. G. Paxinos and C. Watson, Eds., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA, 6th edition, 2006.
  18. S. L. B. Kristiansen and J. R. Nyengaard, “Digital stereology in neuropathology,” APMIS, vol. 120, no. 4, pp. 327–340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Schmitz and P. R. Hof, “Design-based stereology in neuroscience,” Neuroscience, vol. 130, no. 4, pp. 813–831, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. S. von Bartheld, “Distribution of particles in the Z-axis of tissue sections: relevance for counting methods,” NeuroQuantology, vol. 10, no. 1, pp. 66–75, 2012. View at Google Scholar · View at Scopus
  21. L. E. Stoeckel, C. C. Stewart, H. R. Griffith et al., “MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer's disease,” Brain Imaging and Behavior, vol. 7, no. 3, pp. 282–292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-M. Chen, C.-C. Fan, M.-S. Chiue, C. Chou, J.-H. Chen, and R.-S. Hseu, “Hemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's disease,” PLoS ONE, vol. 8, no. 12, Article ID e82561, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bhattacharjee, Y. Zhao, J. M. Hill et al., “Selective accumulation of aluminum in cerebral arteries in Alzheimer's disease (ad),” Journal of Inorganic Biochemistry, vol. 126, pp. 35–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Chen, B. Zhang, and M. Toborek, “Autophagy is involved in nanoalumina-induced cerebrovascular toxicity,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 2, pp. 212–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A. F. Silva Jr., M. S. S. Aguiar, O. S. Carvalho Jr. et al., “Hippocampal neuronal loss, decreased GFAP immunoreactivity and cognitive impairment following experimental intoxication of rats with aluminum citrate,” Brain Research, vol. 1491, pp. 23–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Bhattacharjee, Y. Zhao, J. M. Hill, M. E. Percy, and W. J. Lukiw, “Aluminum and its potential contribution to Alzheimer's disease (AD),” Frontiers in Aging Neuroscience, vol. 6, article 62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. R. Walton, “Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease,” NeuroToxicology, vol. 30, no. 6, pp. 1059–1069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. L. Zhang, P. Boscolo, P. Y. Niu et al., “How do rat cortical cells cultured with aluminum die: necrosis or apoptosis?” International Journal of Immunopathology and Pharmacology, vol. 21, no. 1, pp. 107–115, 2008. View at Google Scholar · View at Scopus
  29. D. V. Krysko, T. Vanden Berghe, K. D'Herde, and P. Vandenabeele, “Apoptosis and necrosis: detection, discrimination and phagocytosis,” Methods, vol. 44, no. 3, pp. 205–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. K. Barbiero, R. M. Santiago, D. S. Persike et al., “Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine,” Behavioural Brain Research, vol. 274, pp. 390–399, 2014. View at Publisher · View at Google Scholar
  31. T. Pang, L. X. Sun, T. Wang, Z. Z. Jiang, H. Liao, and L. Y. Zhang, “Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPARγ and the Akt/GSK-3β pathway,” Acta Pharmacologica Sinica, vol. 35, no. 6, pp. 727–737, 2014. View at Publisher · View at Google Scholar
  32. R. Gupta and L. K. Gupta, “Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease,” Pharmacology Biochemistry and Behavior, vol. 102, no. 2, pp. 184–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Q. Xiang, S. S. Tang, L. Y. Jiang et al., “PPARγ agonist pioglitazone improves scopolamine-induced memory impairment in mice,” Journal of Pharmacy and Pharmacology, vol. 64, no. 4, pp. 589–596, 2012. View at Publisher · View at Google Scholar · View at Scopus